Shaping the future of
R&D to Commercial Partnerships
At MBM, we believe that meaningful impact on human health happens only by joining forces with other industry experts. Currently, we are seeking partnerships in the following segments
Clinical Research and Drug Development Collaborations
Our comprehensive technology platforms have been demonstrated to be powerful tools for guiding clinical decisions in multiple cancer indications including colorectal, prostate, and lung cancers. Our portfolio of technology solutions can also be used in precision drug development processes, including biomarker-driven patient stratification, disease monitoring and treatment response. We are seeking partnerships with medical, industry and academic partners to develop new indications using our technology platforms. To initiate a study, contact us via the form below.
Pipeline Development Collaborations
We are always on the lookout for the next breakthrough innovation that addresses significant clinical needs for patient care in China. Our closed loop commercialization capabilities allows us to work with both global and local partners at different stages of the product development cycle. We follow a methodical process to evaluate new technologies, but are flexible in creating a win-win partnership structure. At the moment, we are strategically interested in licensing technologies in the fields of precision diagnostics and cell therapy. To begin a discussion and learn more about what we can offer, contact us via the form below